The information contained within this announcement is deemed by the Company to constitute inside information pursuant to Article 7 of EU Regulation 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 as amended.
7 March 2022
Osirium Technologies plc
("Osirium" or the "Company")
Result of General Meeting
Osirium Technologies plc (AIM: OSI), a leading vendor of cloud-based cybersecurity software, announces that at the Company's General Meeting, held earlier today, the resolution put to Shareholders was duly passed on a poll vote, as follows:
| Resolution | Number of votes for* | % of votes for | Number of votes against | % of votes against | Total number of votes | Votes withheld** |
| To authorise allotment and disapply statutory pre-emption rights | 12,951,781 | 99.66% | 44,049 | 0.34% | 12,995,830 | - |
* Includes discretionary votes.
**A vote withheld is not a vote in law and is not counted towards votes cast "For" or "Against" a resolution.
Accordingly, following the passing of the Resolution at the General Meeting, the Company has conditionally raised £1 million pursuant to the Placing and Subscription, details of which were announced on 11 February 2022. Application has been made for the admission of the Second Placing Shares and Subscription Shares to trading on AIM ("Second Admission") which is expected to occur on or around 10 March 2022.
Directors' holdings
Details of the interests of the Directors who participated in the Subscription and their resultant holdings of Ordinary Shares following Second Admission are as follows:
| Director | Existing number of Ordinary Shares held | Number of Subscription Shares | Total number of Ordinary Shares held following Second Admission | % of enlarged share capital following Second Admission |
| Simon Lee | 406,083 | 500,000 | 906,083 | 1.97% |
| David Guyatt1 | 1,579,776 | 3,333,333 | 4,913,109 | 10.67% |
| Rupert Hutton1 | 137,142 | 116,667 | 253,809 | 0.55% |
| Steve Purdham | 102,597 | 83,333 | 185,930 | 0.40% |
1 includes spouse
Total voting rights
Following Second Admission, the number of Ordinary Shares in issue and number of voting rights will be 46,048,681. The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Unless otherwise defined, all capitalised terms used but not defined in this announcement shall have the meaning given to them in the Circular dated 14 February 2022, a copy of which is available to view on the Company's website, www.osirium.com.
| Contacts: | |
| | |
| Osirium Technologies plc | Tel: +44 (0)1183 242 444 |
| David Guyatt, CEO | |
| Rupert Hutton, CFO | |
| | |
| Allenby Capital Limited (Nominated adviser and broker) | Tel: +44 (0)20 3328 5656 |
| James Reeve / George Payne (Corporate Finance) | |
| Tony Quirke (Sales and Corporate Broking) | |
| | |
| Alma PR (Financial PR adviser) | Tel: +44 (0)20 3405 0205 |
| Hilary Buchanan | |
| Josh Royston Kieran Breheny | |
| | |
About Osirium Technologies Plc
Osirium Technologies plc (AIM: OSI) is a leading UK-based cybersecurity software vendor delivering Privileged Access Management (PAM), Privileged Endpoint Management (PEM) and Osirium Automation solutions that are uniquely simple to deploy and maintain.
With privileged credentials involved in over 80% of security breaches, customers rely on Osirium PAM's innovative technology to secure their critical infrastructure by controlling 3rd party access, protecting against insider threats, and demonstrating rigorous compliance. Osirium Automation delivers time and cost savings by automating complex, multi-system processes securely, allowing them to be delegated to Help Desk engineers or end-users and to free up specialist IT resources. The Osirium PEM solution balances security and productivity by removing risky local administrator rights from users, while at the same time allowing escalated privileges for specific applications.
Founded in 2008 and with its headquarters in Reading, UK, the Company's shares were admitted to trading on AIM in April 2016. For further information please visit www.osirium.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
